Revvity | DEBITO



Debt Cambiamento Data
Adcock Ingram Holdings ZAR 280.54M 199.53M 2024-06
Agilent USD 3.36B 27M 2025-01
Align Technology USD 0 0 2024-12
Bio Techne USD 300M 0 2024-12
Bio-Rad Laboratories USD 1.2B 276K 2024-12
Bruker USD 2.09B 203M 2024-12
Celltrion KRW 2.19T 18.16B 2024-09
Charles River Laboratories USD 2.24B 86.72M 2024-12
Cspc Pharmaceutical CNY 507.33M 118.46M 2024-12
Danaher USD 16.01B 1.52B 2024-12
Dentsply International USD 2.14B 82M 2024-12
Dianthus Therapeutics USD 1.49M 1.49M 2024-12
Ecofibre AUD 25.49M 285K 2024-06
Edwards Lifesciences USD 597.7M 200K 2024-12
Exact Sciences USD 2.59B 8K 2024-12
Hologic USD 2.54B 9.7M 2024-12
Illumina USD 1.99B 1000K 2024-12
Intuitive Surgical USD 0 0 2024-12
IQVIA Holdings USD 13.98B 471M 2024-12
Kangmei Pharma CNY 253.72M 1.04B 2024-09
Knight Therapeutics CAD 58.22M 109K 2024-09
Laboratorios Farma EUR 114.41M 6.75M 2024-12
Laboratory Of America USD 6.41B 421.6M 2024-12
Malin Corporation EUR 0 100K 2024-06
Medical Developments International AUD 2.29M 140K 2024-06
Mettler Toledo International USD 2.01B 63.6M 2024-12
Myriad Genetics USD 39.6M 600K 2024-12
Neuren Pharmaceuticals AUD 0 0 2024-12
Organigram Holdings CAD 44.74M 12.56M 2024-12
Patterson Companies USD 750.64M 66.24M 2025-01
Pharma Mar EUR 51.08M 1.99M 2024-12
Qiagen NV USD 1.39B 528.29M 2024-12
Quest Diagnostics USD 6.22B 753M 2024-12
Quidel USD 2.48B 67.3M 2024-12
Repligen USD 525.57M 3.96M 2024-12
Revvity USD 3.15B 36.03M 2024-12
Sartorius EUR 4.63B 69.9M 2025-03
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Thermo Fisher Scientific USD 31.28B 4.04B 2024-12
Tilray USD 351.72M 15.26M 2024-11
Waters USD 1.63B 199.76M 2024-12
Zz Pientze Pharmaceu 1.18B 115.85M 2024-09



Revvity DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.